Filing Details

Accession Number:
0001140361-17-006895
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-14 12:55:32
Reporting Period:
2017-02-13
Filing Date:
2017-02-14
Accepted Time:
2017-02-14 12:55:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561387 Health Insurance Innovations Inc. HIIQ Insurance Agents, Brokers & Service (6411) 461282634
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569128 D Michael Hershberger C/O Health Insurance Innovations, Inc.
15438 North Florida Ave., Suite 201
Tampa FL 33613
Cfo, Secretary And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2017-02-13 6,337 $17.69 127,032 No 4 S Direct
Class A Common Stock Disposition 2017-02-13 3,663 $19.01 123,369 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Appreciation RIghts $10.45 2021-05-21 25,000 25,000 Direct
Common Stock Stock Appreciation RIghts $4.95 2022-07-01 30,000 30,000 Direct
Common Stock Stock Appreciation RIghts $4.99 2022-09-16 30,000 30,000 Direct
Common Stock Stock Appreciation RIghts $5.20 2023-09-16 40,972 40,972 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-05-21 25,000 25,000 Direct
2022-07-01 30,000 30,000 Direct
2022-09-16 30,000 30,000 Direct
2023-09-16 40,972 40,972 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2016.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $17.50 to $18.15. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price.
  3. The price in Column 4 is a weighted average price. The prices actually received ranged from $18.775 to $19.25. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price.
  4. These stock-settled stock appreciation rights were granted under the Issuer's Long-Term Incentive Plan and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Long-Term Incentive Plan and an award agreement under the Long-Term Incentive Plan.
  5. These stock-settled stock appreciation rights were granted under the Issuer's Long-Term Incentive Plan and vest 50% on the first anniversary of grant date and 25% on each of the second and third anniversaries, subject to the terms of the Long-Term Incentive Plan and an award agreement under the Long-Term Incentive Plan.